Faculty Profiles

Robert Guyton

Robert A. Guyton, MD

Distinguished Charles Ross Hatcher, Jr., Professor of Surgery

Director, Cardiothoracic Research Lab (CTRL), Division of Cardiothoracic Surgery, Emory

Chief of Cardiothoracic Surgery, Emory University Hospital Midtown

Telephone: 404.778.3836

Email: rguyton@emory.edu

Certification: American Board of Surgery, American Board of Thoracic Surgery

Year Joined Emory as a Faculty Member: 1980


Dr. Guyton served as chief of the Division of Cardiothoracic Surgery at Emory from 1990-2017, and program director of the Emory CT Surgery Residency from 1990-2018. Under his guidance, Emory's CT surgery program achieved national recognition as one of the country's top programs in areas including off-pump coronary revascularization, congenital cardiac surgery, robotic mitral surgery, major aortic surgery, robotic-assisted coronary bypass, and transcatheter aortic valve replacement.

Dr. Guyton has influenced his field in other fundamental ways as well. He has been responsible for the education of some of the most accomplished and successful CT surgeons in the country and participated in the training of more than 140 resident physicians. Emory's CT surgery residency program accounts for approximately 5% of all active cardiac surgeons in the country today.

In 2007, Dr. Guyton joined Emory CT surgeon scientist Dr. Vinod Thourani and Emory cardiologists Dr. Vasilis Babaliaros and Dr. Peter Block as one of the local surgical Co-PIS of the multi-center PARTNER I trial of transcatheter aortic valve replacement (TAVR). The results of the national trial influenced FDA approval of the SAPIEN transfemoral transcatheter heart valve for treatment of high-risk patients with aortic stenosis in 2011.

In 2014, Dr. Guyton was inducted into Emory's Millipub Club for being co-author of a paper that has been cited more than 1,000 times in the literature. The paper, "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery," was published in the October 2010 edition of New England Journal of Medicine, and it reported the results of comparing TAVR to such standard therapies as balloon aortic valvuloplasty. Dr. Guyton and his co-authors concluded that the reduced mortality among patients treated with TAVR as opposed to traditional methods was significant.


View Dr. Guyton's publications in PubMed.


  • Emory University Hospital Midtown

  • Emory University Hospital

  • Children's Healthcare of Atlanta at Egleston

  • Grady Memorial Hospital

  • Atlanta VA Medical Center


  • MD, Harvard Medical School, Class of 1971

  • Internship, General Surgery and Cardiothoracic Surgery Residencies, Clinical Fellowship in Surgery, Massachusetts General Hospital, 1971-1978

  • Chief Resident in Cardiac Surgery, Boston Children's Hospital, 1978-1979

Honors and Awards

  • 2019 Arnall Patz Lifetime Achievement Award, Emory University School Medicine

  • 2017 Presidential Citation, American College of Cardiology

  • Lifetime Achievement Award, Atlanta Business Chronicle's Annual Health Care Heroes, 2017

  • 2016 Distinguished Service Award, American College of Cardiology

  • Atlanta's Top Doctors, Atlanta Magazine, 2010-2019

Current Organizational Memberships

  • American Association for Thoracic Surgery

  • American College of Cardiology

  • American Surgical Association

  • Society of Thoracic Surgeons

  • Southern Thoracic Surgical Association

  • Thoracic Surgery Directors Association

  • Thoracic Surgery Foundation for Research and Education

Editorial Boards

  • Clinical Cardiology

Clinical and Research Interests

  • Off pump coronary artery bypass

  • Bypass surgery

  • Cardiac revascularization

  • Mitral valve prolapse

  • Myocardial infarction

  • Valve repair/replacement

  • Adult congenital heart surgery